Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Design, synthesis and biological characterization of selective LIMK inhibitors.

Boland S, Bourin A, Alen J, Geraets J, Schroeders P, Castermans K, Kindt N, Boumans N, Panitti L, Vanormelingen J, Fransen S, Van de Velde S, Defert O.

Bioorg Med Chem Lett. 2015 Sep 15;25(18):4005-10. doi: 10.1016/j.bmcl.2015.07.009. Epub 2015 Jul 10.

PMID:
26233434
2.

Design, synthesis, and biological evaluation of novel, highly active soft ROCK inhibitors.

Boland S, Bourin A, Alen J, Geraets J, Schroeders P, Castermans K, Kindt N, Boumans N, Panitti L, Fransen S, Vanormelingen J, Stassen JM, Leysen D, Defert O.

J Med Chem. 2015 May 28;58(10):4309-24. doi: 10.1021/acs.jmedchem.5b00308. Epub 2015 May 6.

PMID:
25898023
3.

Novel Roflumilast analogs as soft PDE4 inhibitors.

Boland S, Alen J, Bourin A, Castermans K, Boumans N, Panitti L, Vanormelingen J, Leysen D, Defert O.

Bioorg Med Chem Lett. 2014 Sep 15;24(18):4594-4597. doi: 10.1016/j.bmcl.2014.07.016. Epub 2014 Jul 12.

PMID:
25149511
4.

3-[2-(Aminomethyl)-5-[(pyridin-4-yl)carbamoyl]phenyl] benzoates as soft ROCK inhibitors.

Boland S, Defert O, Alen J, Bourin A, Castermans K, Kindt N, Boumans N, Panitti L, Van de Velde S, Stalmans I, Leysen D.

Bioorg Med Chem Lett. 2013 Dec 1;23(23):6442-6. doi: 10.1016/j.bmcl.2013.09.040. Epub 2013 Sep 21.

PMID:
24119557
5.

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity.

Vogels R, Zuijdgeest D, van Rijnsoever R, Hartkoorn E, Damen I, de B├ęthune MP, Kostense S, Penders G, Helmus N, Koudstaal W, Cecchini M, Wetterwald A, Sprangers M, Lemckert A, Ophorst O, Koel B, van Meerendonk M, Quax P, Panitti L, Grimbergen J, Bout A, Goudsmit J, Havenga M.

J Virol. 2003 Aug;77(15):8263-71.

Supplemental Content

Loading ...
Support Center